New cancer drugs are making headlines, Iressa, Velcade, Avastin

New cancer drugs are making headlines, Iressa, Velcade, Avastin.

They each have an important new mechanism of action.

Iressa (gefitinib) is a new ORAL drug for lung cancer. It's an "epidermal growth factor inhibitor"...just for patients whose cancer progresses despite standard chemotherapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote